# The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease

> **NCT01039558** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** ecabet sodium
- **DRUG:** lansoprazole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01039558
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01039558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01039558, "The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01039558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*